SEC Comment Letter 0000000000-24-013164 to Burning Rock Biotech Ltd (BNR)
Burning Rock Biotech Ltd
Date: Nov. 27, 2024 · CIK: 0001792267 · Accession: 0000000000-24-013164
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 001-39316
Letter
November 27, 2024 Yusheng Han Chief Executive Officer Burning Rock Biotech Ltd No. 5, Xingdao Ring Road North, International Bio Island Guangzhou, 510005 Peoples Republic of China Re:Burning Rock Biotech Ltd Form 20-F for Fiscal Year Ended December 31, 2023 File No. 001-39316 Dear Yusheng Han: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services
Show Raw Text
November 27, 2024
Yusheng Han
Chief Executive Officer
Burning Rock Biotech Ltd
No. 5, Xingdao Ring Road North, International Bio Island
Guangzhou, 510005
Peoples Republic of China
Re:Burning Rock Biotech Ltd
Form 20-F for Fiscal Year Ended December 31, 2023
File No. 001-39316
Dear Yusheng Han:
We have completed our review of your filing. We remind you that the company and
its management are responsible for the accuracy and adequacy of their disclosures,
notwithstanding any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services